1BMQ | A:131-297 | CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE) WITH A PEPTIDE BASED INHIBITOR, (3S )-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL }AMINO)-4-OXOBUTANAMIDE |
1CP3 | A:35-277; B:35-277 | CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC |
1F1J | A:58-302; B:357-602 | CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO |
1F9E | A:149-299; C:149-299; E:149-299; G:149-299; I:149-299; K:149-299 | CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO |
1GFW | A:29-173 | THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR. |
1GQF | A:140-402H; B:140-402H | CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7 |
1I3O | C:148-297; A:148-296 | CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3 |
1I4O | B:58-303; A:55-303 | CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX |
1I51 | A:58-196; C:58-196 | CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP |
1IBC | A:131-297 | CRYSTAL STRUCTURE OF INHIBITED INTERLEUKIN-1BETA CONVERTING ENZYME |
1ICE | A:131-297 | STRUCTURE AND MECHANISM OF INTERLEUKIN-1BETA CONVERTING ENZYME |
1JXQ | B:148-403; D:148-403; A:139-403; C:139-403 | STRUCTURE OF CLEAVED, CARD DOMAIN DELETED CASPASE-9 |
1K86 | A:57-303; B:57-303 | CRYSTAL STRUCTURE OF CASPASE-7 |
1K88 | A:56-303; B:56-303 | CRYSTAL STRUCTURE OF PROCASPASE-7 |
1KMC | A:150-402; B:149-401 | CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX |
1NME | A:29-174 | STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE |
1NMQ | A:34-277; B:34-277 | EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS |
1NMS | A:34-277; B:34-277 | CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR |
1NW9 | B:140-416 | STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP-BIR3 |
1PAU | A:150-295 | CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO |
1PYO | C:8-168; A:9-167 | CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP-GLU-SER-ASP-CHO |
1QDU | A:149-299; C:149-299; E:149-299; G:149-299; I:149-299; K:149-299 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK |
1QTN | A:223-374 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE |
1QX3 | A:35-277 | CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OF UNLIGANDED HUMAN CASPASE-3 |
1RE1 | A:150-295 | CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR |
1RHJ | A:150-295; C:650-795 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR |
1RHK | A:150-295 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL-PROPYL-KETONE INHIBITOR |
1RHM | A:150-295; C:650-795 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR |
1RHQ | A:150-295; D:150-295 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR |
1RHR | A:150-295 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR |
1RHU | A:150-295 | CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 5,6,7 TRICYCLIC PEPTIDOMIMETIC INHIBITOR |
1RWK | A:125-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-(2-MERCAPTO-ACETYLAMINO)-4-OXO-PENTANOIC ACID |
1RWM | A:125-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[2-(5-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID |
1RWN | A:125-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID |
1RWO | A:125-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-PENTANOIC ACID |
1RWP | A:125-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID |
1RWV | A:125-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 5-[5-(1-CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-5-PHENYL-PENTYLSULFAMOYL]-2-HYDROXY-BENZOIC ACID |
1RWW | A:123-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)-AMINO]-BUTYRIC ACID |
1RWX | A:120-297 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4-(QUINOXALIN-2-YLOXY)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-BUTYRIC ACID |
1SC1 | A:131-297 | CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN CASPASE-1 C285A MUTANT |
1SC3 | A:125-297 | CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX WITH MALONATE |
1SC4 | A:132-297 | CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT AFTER REMOVAL OF MALONATE |
1SHJ | A:57-303; B:55-303 | CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR |
1SHL | A:57-303; B:57-303 | CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR |
2AR9 | A:140-416; C:140-416; D:140-416; B:140-416 | CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9 |
2C1E | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. |
2C2K | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. |
2C2M | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. |
2C2O | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS. |
2C2Z | A:223-372 | CRYSTAL STRUCTURE OF CASPASE-8 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITOR |
2CDR | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. |
2CJX | A:29-175 | EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS |
2CJY | A:29-175 | EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS |
2CNK | A:29-174 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. |
2CNL | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. |
2CNN | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. |
2CNO | A:29-175 | CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS. |
2DKO | A:29-174 | EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS |
2FQR | | [entry was replaced by entry 2HBQ without any CATH domain information] |
2FQS | | [entry was replaced by entry 2HBR without any CATH domain information] |
2FQU | | [entry was replaced by entry 2HBY without any CATH domain information] |
2H5I | A:29-174 | CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-DEVD-CHO |
2H5J | A:34-174; C:35-174 | CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO |
2H65 | C:34-174; A:35-174 | CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO |
2J30 | A:29-278 | THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3 |
2J31 | A:29-278 | THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3 |
2J32 | A:29-278 | THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3 |
2J33 | A:29-278 | THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3 |
2P2C | C:8-168; E:8-167 | INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) |
2QL5 | A:57-196; C:357-496 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DMQD-CHO |
2QL7 | A:57-196; C:357-496 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO |
2QL9 | A:57-196; C:357-496 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO |
2QLB | A:57-196; C:357-496 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO |
2QLF | C:357-496; A:58-196 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO |
2QLJ | A:57-196; C:357-496 | CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-WEHD-CHO |
3DEH | D:34-276; A:34-277; C:34-277; B:34-277 | CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-1,3, 4-TRIONE DERIVATIVE INHIBITORS |
3DEI | A:34-277; B:33-277; C:33-277; D:32-276 | CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-1,3, 4-TRIONE DERIVATIVE INHIBITORS |
3DEJ | D:34-276; A:34-277; C:34-277; B:34-277 | CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-1,3, 4-TRIONE DERIVATIVE INHIBITORS |
3DEK | A:34-277; D:34-277; B:34-277; C:34-277 | CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-1,3, 4-TRIONE DERIVATIVE INHIBITORS |
3EDQ | C:34-174; A:35-174 | CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-LDESD-CHO |
3EDR | C:352-496; A:58-196 | THE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-LDESD-CHO |
3GJQ | A:34-174; C:35-174 | CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES |
3GJR | A:34-174; C:34-174 | CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES |
3GJS | A:34-174; C:35-174 | CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES |
3GJT | A:34-174; C:35-174 | CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES |
3IBC | A:57-196; C:357-496 | CRYSTAL STRUCTURE OF CASPASE-7 INCOMPLEX WITH ACETYL-YVAD-CHO |
3IBF | C:352-496; A:57-196 | CRYSTAL STRUCTURE OF UNLIGANDED CASPASE-7 |